
5.39MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US28622K1043
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
27.20
Dividend Share
-
Dividend Yield
-
Earnings Share
-1778.72
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
2,578,688
Gross Profit TTM
-528,822
EBITDA
-11,544,472
Profit Margin
0.00%
Return On Assets TTM
-32.97%
Return On Equity TTM
-105.22%
Revenue Per Share TTM
19.082
Qtly Revenue Growth YOY
-45.80%
Diluted Eps TTM
-1778.72
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
2.047
Price Book MRQ
0.3222
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
158.20
13.90%267.34
1.62%552.84
0.91%833.39
0.56%1015.47
0.37%995.00
0.00%120.00
0.00%128.50
-0.56%30.10
-0.53%210.42
-0.52%